Ligand validation:6G5P

MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6G5P_MES_A_903	92%	21%	0.086	0.975	1.73	1.61	1	5	1	0	100%	0.73
5PZ8_MES_A_904	90%	18%	0.097	0.979	1.07	2.42	1	5	3	0	100%	0.59
5PYL_MES_A_904	86%	20%	0.094	0.963	1.13	2.24	1	4	4	0	100%	0.59
5PYM_MES_A_904	84%	18%	0.103	0.966	1.58	1.91	1	5	2	0	100%	0.59
5PYZ_MES_A_904	84%	19%	0.108	0.97	1	2.42	1	4	2	0	100%	0.59
5PXN_MES_A_904	84%	16%	0.11	0.971	1.01	2.67	1	6	2	0	100%	0.59
2IUY_MES_B_1355	100%	9%	0.026	0.997	1.73	2.73	1	7	0	0	100%	1
3DPJ_MES_A_192	100%	8%	0.022	0.995	2.2	2.41	1	6	3	0	100%	1
5A0C_MES_B_1002	100%	11%	0.033	0.993	1.84	2.39	3	3	0	0	100%	1
8AJQ_MES_H_201	100%	38%	0.037	0.992	1.52	0.93	1	1	0	0	100%	1
5APG_MES_A_1187	100%	12%	0.044	0.99	1.48	2.57	3	6	0	0	100%	0.9292

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.